NCT01984099View on ClinicalTrials.gov

RCT on the Efficacy of Methotrexate for the Prevention of GTD

PHASE3CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Hydatidiform Mole
Interventions
DRUG

Methotrexate

Patients will be given a single course of methotrexate within fourteen days from molar evacuation.

DRUG

Vitamin B Complex

Patients will be given a placebo in a form of Vitamin B Complex (Bee ALL), intramuscularly or intravenously.

Trial Locations (1)

1000

Philippine General Hospital, University of the Philippines Manila, Taft Avenue, Ermita, Manila

All Listed Sponsors
lead

University of the Philippines

OTHER

NCT01984099 - RCT on the Efficacy of Methotrexate for the Prevention of GTD | Biotech Hunter | Biotech Hunter